Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Baxter Healthcare (Enlon product line)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of pharmaceutical products. The enlon product line includes edrophonium chloride injection, edrophonium chloride, atropine sulphate, ampule recommended for the diagnosis of myasthenia.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • One Baxter Parkway
  • Deerfield, IL 60015
  • United States

Baxter Healthcare (Enlon product line) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Baxter Healthcare (Enlon product line)‘s full profile, request access.

Request full access to PitchBook

Baxter Healthcare (Enlon product line) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Baxter Healthcare (Enlon product line)‘s full profile, request access.

Request full access to PitchBook